Flagship Private Wealth’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,347
Closed -$74.2K 103
2024
Q3
$74.2K Hold
10,347
0.04% 99
2024
Q2
$75.8K Buy
+10,347
New +$90.3K 0.04% 87
2022
Q1
Sell
-9,469
Closed -$242K 76
2021
Q4
$242K Buy
+9,469
New +$262K 0.18% 70
2021
Q3
Sell
-6,514
Closed -$261K 213
2021
Q2
$261K Buy
6,514
+3,505
+116% +$142K 0.2% 66
2021
Q1
$130K Buy
3,009
+1,774
+144% +$81.8K 0.11% 76
2020
Q4
$50.6K Buy
+1,235
New +$36.8K 0.05% 118

Other funds holding MSOS

Flagship Private Wealth's MSOS Position: Q4 2024 in Review

Flagship Private Wealth sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q4 2024, closing a stake of 10,347 shares — an estimated $74.2K sold.

Flagship Private Wealth first reported a position in MSOS in Q4 2020 and held it in 6 quarters. The position peaked at $261K in Q2 2021. 178 funds tracked by Wall St. Rank hold MSOS as of Q4 2024.

  • Flagship Private Wealth reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q4 2024 after selling out during the quarter.
  • Flagship Private Wealth sold 10,347 AdvisorShares Pure US Cannabis ETF shares in Q4 2024, an estimated $74.2K.
  • Flagship Private Wealth first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2020 and held it in 6 quarters.
  • Flagship Private Wealth's AdvisorShares Pure US Cannabis ETF position peaked at $261K in Q2 2021.
  • 178 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q4 2024.

Based on Flagship Private Wealth's 13F filing for Q4 2024, filed 21 Jan 2025.